Half Yearly Results Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 10.25% vs 15.38% in Sep 2024
Standalone Net Profit
Growth in half year ended Sep 2025 is 39.19% vs 12.31% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 15.57% vs 56.00% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 18.18% vs 18.92% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Sep 2024
Compare Half Yearly Results Of Jagsonpal Pharma With
Figures in Cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
150.08
237.98
-87.90
-36.94%
Other Operating Income
0.00
0.00
0.00
Total Operating income
150.08
237.98
-87.90
-36.94%
Raw Material Cost
9.18
106.04
-96.86
-91.34%
Purchase of Finished goods
46.49
30.97
15.52
50.11%
(Increase) / Decrease In Stocks
-1.51
2.93
-4.44
-151.54%
Employee Cost
37.62
32.69
4.93
15.08%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
3.12
0.00
3.12
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
24.53
30.85
-6.32
-20.49%
Total Expenditure (Excl Depreciation)
119.43
203.48
-84.05
-41.31%
Operating Profit (PBDIT) excl Other Income
30.65
34.50
-3.85
-11.16%
Other Income
5.85
11.25
-5.40
-48.00%
Operating Profit (PBDIT)
36.50
45.75
-9.25
-20.22%
Interest
0.52
0.49
0.03
6.12%
Exceptional Items
0.00
0.04
-0.04
-100.00%
Gross Profit (PBDT)
35.98
45.30
-9.32
-20.57%
Depreciation
4.74
2.69
2.05
76.21%
Profit Before Tax
31.24
42.62
-11.38
-26.70%
Tax
7.87
10.05
-2.18
-21.69%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
23.37
32.57
-9.20
-28.25%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
23.37
32.57
-9.20
-28.25%
Equity Capital
13.33
94.00
-80.67
-85.82%
Face Value
2.00
1.00
0.00
Reserves
239.51
0.00
239.51
Earnings per share (EPS)
3.51
0.35
3.16
902.86%
Diluted Earnings per share
3.45
0.39
3.06
784.62%
Operating Profit Margin (Excl OI)
20.42%
14.50%
0.00
5.92%
Gross Profit Margin
23.97%
19.04%
0.00
4.93%
PAT Margin
15.57%
13.69%
0.00
1.88%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 150.08 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 10.25% vs 15.38% in Sep 2024
Half Yearly - Standalone Net Profit
Standalone Net Profit 23.37 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 39.19% vs 12.31% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 30.65 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 15.57% vs 56.00% in Sep 2024
Half Yearly - Interest
Interest 0.52 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 18.18% vs 18.92% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.42%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
